The speciality chemicals unit of the Deepak group is likely to sell stock to existing shareholders in the second quarter. The longer-term plans of the company and methods to fund those plans include the possibility of a rights issue, the Mint report suggests.
Meanwhile, on May 21 2014, the company announced that it has commissioned balance capacities of Optical Brightening Agent (OBA) after completion of successful trial runs of production at its new greenfield plant at Dahej district Bharuch in the Gujarat.
The company, which has nearly doubled its revenues in FY14 to Rs 1,271 crore from Rs 661 crore in FY11, is aiming for a turnover of Rs 2,000 crore in FY16.
The stock opened at Rs 812 and touched a record high of Rs 897 on NSE. A combined 13,050 shares changed hands on the counter in early morning deals on the NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
